Bipolar Research Today is a free monthly online journal that collates and summarizes the latest research about Bipolar, including details on bipolar disorder, symptoms, treatment, depression, medication.

Volume 2 (2005), Issue 7 (July)

1. Long-term treatment of adjunctive quetiapine for bipolar mania.
   Prog Neuropsychopharmacol Biol Psychiatry, 29(5): 763-6. [Abstract] [Full-text]
2. Interferon-induced depression: strategies in treatment.
   Prog Neuropsychopharmacol Biol Psychiatry, 29(5): 808-18. [Abstract] [Full-text]
3. Genetic models of schizophrenia and bipolar disorder: overlapping inheritance or discrete genotypes?
   Eur Arch Psychiatry Clin Neurosci, 255(3): 159-66. [Abstract] [Full-text]
4. A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression.
   Am J Psychiatry, 162(7): 1351-60. [Abstract] [Full-text]
5. National trends in hospitalization of youth with intentional self-inflicted injuries.
   Am J Psychiatry, 162(7): 1328-35. [Abstract] [Full-text]
6. Olanzapine versus lithium in the maintenance treatment of bipolar disorder: a 12-month, randomized, double-blind, controlled clinical trial.
   Am J Psychiatry, 162(7): 1281-90. [Abstract] [Full-text]
7. Comparison of rapid-cycling and non-rapid-cycling bipolar disorder based on prospective mood ratings in 539 outpatients.
   Am J Psychiatry, 162(7): 1273-80. [Abstract] [Full-text]
8. Familial variation in episode frequency in bipolar affective disorder.
   Am J Psychiatry, 162(7): 1266-72. [Abstract] [Full-text]
9. Structural brain magnetic resonance imaging of limbic and thalamic volumes in pediatric bipolar disorder.
   Am J Psychiatry, 162(7): 1256-65. [Abstract] [Full-text]
10. 'Bipolarity' in bipolar disorder: distribution of manic and depressive symptoms in a treated population.
    Br J Psychiatry, 187: 87-8. [Abstract] [Full-text]
11. MLC1 gene is associated with schizophrenia and bipolar disorder in Southern India.
    Biol Psychiatry, 58(1): 16-22. [Abstract] [Full-text]
12. A case of hydrocephalus occlusus presenting as bipolar disorder.
    Acta Psychiatr Scand, 112(2): 159-62; discussion 162-3. [Abstract] [Full-text]
13. Evidence for theory of mind deficits in euthymic patients with bipolar disorder.
    Acta Psychiatr Scand, 112(2): 110-6. [Abstract] [Full-text]
14. One-year outcome with antidepressant--treatment of bipolar depression.
    Acta Psychiatr Scand, 112(2): 105-9. [Abstract] [Full-text]
15. Bipolar disorder in women: reproductive events and treatment considerations.
    Acta Psychiatr Scand, 112(2): 88-96. [Abstract] [Full-text]
16. A review of the possible relevance of inositol and the phosphatidylinositol second messenger system (PI-cycle) to psychiatric disorders--focus on magnetic resonance spectroscopy (MRS) studies.
    Hum Psychopharmacol, 20(5): 309-26. [Abstract] [Full-text]
17. Frontotemporal alterations in pediatric bipolar disorder: results of a voxel-based morphometry study.
    Arch Gen Psychiatry, 62(7): 734-41. [Abstract] [Full-text]
18. Linkage and candidate gene analysis of 14q22-24 in bipolar disorder: support for GCHI as a novel susceptibility gene.
    Am J Med Genet B Neuropsychiatr Genet, 136(1): 75-80. [Abstract] [Full-text]
19. Gene expression analysis of peripheral blood leukocytes from discordant sib-pairs with schizophrenia and bipolar disorder reveals points of convergence between genetic and functional genomic approaches.
    Am J Med Genet B Neuropsychiatr Genet, 136(1): 12-25. [Abstract] [Full-text]
20. XBP1 gene polymorphism (-116C/G) and personality.
    Am J Med Genet B Neuropsychiatr Genet, 136(1): 103-5. [Abstract] [Full-text]
21. Scale for the evaluation of communication disorders in patients with schizophrenia: a validation study.
    Schizophr Res, 77(1): 75-84. [Abstract] [Full-text]
22. No association between common variations in the neuronal nicotinic acetylcholine receptor alpha2 subunit gene (CHRNA2) and bipolar I disorder.
    Psychiatry Res, 135(3): 171-7. [Abstract] [Full-text]
23. Cognitive behavior therapy for chronic insomnia occurring within the context of medical and psychiatric disorders.
    Clin Psychol Rev, 25(5): 559-92. [Abstract] [Full-text]
24. Size and burden of depressive disorders in Europe.
    Eur Neuropsychopharmacol, 15(4): 411-23. [Abstract] [Full-text]
25. Prevalence and burden of bipolar disorders in European countries.
    Eur Neuropsychopharmacol, 15(4): 425-34. [Abstract] [Full-text]
26. Lamotrigine in the treatment of bipolar disorder.
    Expert Opin Pharmacother, 6(8): 1401-8. [Abstract] [Full-text]
27. Family history validation of a definition of mixed depression.
    Compr Psychiatry, 46(3): 159-66. [Abstract] [Full-text]
28. Relationship between criminal arrest and community treatment history among patients with bipolar disorder.
    Psychiatr Serv, 56(7): 847-52. [Abstract] [Full-text]
29. The impact of lithium long-term medication on suicidal behavior and mortality of bipolar patients.
    Arch Suicide Res, 9(3): 307-19. [Abstract] [Full-text]
30. Newer prophylactic agents for bipolar disorder and their influence on suicidality.
    Arch Suicide Res, 9(3): 301-6. [Abstract] [Full-text]
31. Suicide in 406 mood-disorder patients with and without long-term medication: a 40 to 44 years' follow-up.
    Arch Suicide Res, 9(3): 279-300. [Abstract] [Full-text]
32. Mania, hypomania, and suicidality: findings from a prospective community study.
    Arch Suicide Res, 9(3): 267-78. [Abstract] [Full-text]
33. Bipolar affective disorders and suicide during psychiatric in-patient treatment.
    Arch Suicide Res, 9(3): 261-6. [Abstract] [Full-text]
34. Suicide in bipolar I disorder in Finland: psychological autopsy findings from the National Suicide Prevention Project in Finland.
    Arch Suicide Res, 9(3): 251-60. [Abstract] [Full-text]
35. Pharmacotherapy of suicidal behavior in bipolar disorder.
    Arch Suicide Res, 9(3): 237-50. [Abstract] [Full-text]
36. Suicidality, bipolar disorders, and pharmacotherapy.
    Arch Suicide Res, 9(3): 231-5. [Abstract] [Full-text]
37. Magnetic resonance imaging studies in early-onset bipolar disorder: a critical review.
    Harv Rev Psychiatry, 13(3): 125-40. [Abstract] [Full-text]
38. Circadian genes and bipolar disorder.
    Ann Med, 37(3): 196-205. [Abstract] [Full-text]
39. Prophylactic lithium response and polymorphism of the brain-derived neurotrophic factor gene.
    Pharmacopsychiatry, 38(4): 166-70. [Abstract] [Full-text]
40. Prevalence and correlates of tobacco use and nicotine dependence among psychiatric patients in India.
    Addict Behav, 30(7): 1290-9. [Abstract] [Full-text]
41. Re-evaluation of randomized control trials of lithium monotherapy: a cohort effect.
    Bipolar Disord, 7(4): 382-7. [Abstract] [Full-text]
42. Patterns of alcohol consumption in bipolar patients comorbid for alcohol abuse or dependence.
    Bipolar Disord, 7(4): 377-81. [Abstract] [Full-text]
43. Clinical correlates and significance of separation anxiety in patients with bipolar disorder.
    Bipolar Disord, 7(4): 370-6. [Abstract] [Full-text]
44. Evidence for orbitofrontal pathology in bipolar disorder and major depression, but not in schizophrenia.
    Bipolar Disord, 7(4): 358-69. [Abstract] [Full-text]
45. Increased risk of hyperthyroidism among patients hospitalized with bipolar disorder.
    Bipolar Disord, 7(4): 351-7. [Abstract] [Full-text]
46. Five-year prospective outcome of psychopathology in the adolescent offspring of bipolar parents.
    Bipolar Disord, 7(4): 344-50. [Abstract] [Full-text]
47. The epidemiology of bipolar disorder: sociodemographic, disability and service utilization data from the Australian National Study of Low Prevalence (Psychotic) Disorders.
    Bipolar Disord, 7(4): 326-37. [Abstract] [Full-text]
48. Safety and tolerability of emerging pharmacological treatments for bipolar disorder.
    Bipolar Disord, 7(4): 307-25. [Abstract] [Full-text]
49. Toward an evidence-based assessment of pediatric bipolar disorder.
    J Clin Child Adolesc Psychol, 34(3): 433-48. [Abstract] [Full-text]
50. Omega-3 fatty acids decreased irritability of patients with bipolar disorder in an add-on, open label study.
    Nutr J, 4(1): 6. [Abstract] [Full-text]
51. Suicide prevention by lithium SUPLI--challenges of a multi-center prospective study.
    Arch Suicide Res, 9(1): 27-34. [Abstract] [Full-text]
52. Deficient hippocampal neuron expression of proteasome, ubiquitin, and mitochondrial genes in multiple schizophrenia cohorts.
    Biol Psychiatry, 58(2): 85-96. [Abstract] [Full-text]
53. Changes in gray matter volume in patients with bipolar disorder.
    Biol Psychiatry, 58(2): 151-7. [Abstract] [Full-text]
54. A frameshift mutation in Disrupted in Schizophrenia 1 in an American family with schizophrenia and schizoaffective disorder.
    Mol Psychiatry, 10(8): 758-64. [Abstract] [Full-text]
55. Genetic tests of biologic systems in affective disorders.
    Mol Psychiatry, 10(8): 719-40. [Abstract] [Full-text]
56. Population-based and family-based studies on the serotonin transporter gene polymorphisms and bipolar disorder: a systematic review and meta-analysis.
    Mol Psychiatry, 10(8): 771-81. [Abstract] [Full-text]
57. The stability of axis I diagnoses in youth across multiple psychiatric hospitalizations.
    Child Psychiatry Hum Dev, 36(1): 53-71. [Abstract] [Full-text]
58. Mitochondrial DNA sequence analysis of patients with 'atypical psychosis'.
    Psychiatry Clin Neurosci, 59(4): 497-503. [Abstract] [Full-text]
59. Relationships between insight and medication adherence in outpatients with schizophrenia and bipolar disorder: prospective study.
    Psychiatry Clin Neurosci, 59(4): 403-9. [Abstract] [Full-text]
60. Considerations in the management of bipolar disorder in women.
    Aust N Z J Psychiatry, 39(8): 662-73. [Abstract] [Full-text]
61. Maintenance therapies in bipolar disorder: focus on randomized controlled trials.
    Aust N Z J Psychiatry, 39(8): 652-61. [Abstract] [Full-text]
62. Assessing cognitive deficits in bipolar disorder: are self-reports valid?
    Psychiatry Res, 136(1): 43-50. [Abstract] [Full-text]
63. Patient-based utilities for bipolar disorder-related health states.
    J Affect Disord, 87(2): 203-10. [Abstract] [Full-text]
64. Identifying "paradigm failures" contributing to treatment-resistant depression.
    J Affect Disord, 87(2): 185-91. [Abstract] [Full-text]

© 2004-2008 Bipolar Research Today. All Rights Reserved.